Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Managing pediatric pneumonia by following guidelines to decrease the use of concurrent asthma medication. Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019
Resource utilization and economic impact of switching uncontrolled asthma and exacerbating COPD patients on monotherapy to fixed dose combination treatment in Germany Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004
Potential economic savings of administration of home intravenous antibiotic therapy to patients with acute respiratory infections in Ireland Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
Integrated care intervention prevents hospitalisations for exacerbations and reduces the disease costs in COPD patients Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011
Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007
Reduction in acute hospital resource use by patients with severe COPD: an integrated facilitated care model Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019 Year: 2020
Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011
In a rural part of Canada, a study of the treatment of asthma attacks shows an over utilisation of salbutamol nebulization and of antibiotics, a less frequent use of steroid inhalation treatments, a lower incidence of environmental modification teaching a Source: Eur Respir J 2003; 22: Suppl. 45, 409s Year: 2003
Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015
Home based therapy combined with self management plans reduces re-admission rates for COPD Source: Annual Congress 2012 - The best abstracts in chronic care Year: 2012
Integrated care reduces hospitalizations in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 348s Year: 2003
Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
A community-based intravenous medication service has proven to be safe, effective and cost-effective for patients with acute respiratory illness Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010